The medical spa industry is booming for good reason. What started as a niche sector has grown into a $20+ billion powerhouse, projected to reach $44–78 billion in the coming years. Medispas have made advanced aesthetic and wellness treatments—like injectables, laser therapies, chemical peels, and more—accessible, affordable, and welcoming to millions
of Americans.
These aren’t shady back-alley operations. They’re often small, local, woman-owned businesses staffed by highly trained physicians, nurse practitioners, physician assistants, and registered nurses. They operate under strict state medical and nursing board oversight, delivering safe, effective care in comfortable, spa-like environments that prioritize patient comfort and results.
Yet despite this success, the medispa industry faces an aggressive push for overly restrictive regulations from groups like the American Medical Association (AMA). Framed as “patient safety,” these efforts risk limiting access, stifling innovation, and threatening thousands of independent practices—especially smaller ones serving diverse and underserved communities.
Medispas have democratized aesthetic medicine. They’ve created over 100,000 jobs nationwide, with the average medispa employing 8–10 staff. Through extensive training programs from organizations like the American Med Spa Association (AmSpa), providers continue to elevate standards and deliver exceptional outcomes.
Patients love the model because it combines medical expertise with genuine care and affordability. The industry’s strong safety record in compliant practices speaks for itself.
Regulation already exists through state boards, HIPAA, OSHA, FDA, and FTC rules. New state-level bills in places like Arizona, Florida, Indiana, and Iowa aim to add practical enhancements like registration and adverse-event reporting—without imposing one-size-fits-all mandates that could hurt small businesses.
Blanket requirements, such as constant on-site physician presence, ignore the realities of modern team-based care and could drive up costs while reducing competition and patient choice.
To cut through the noise and provide a clear, evidence-based defense of the medispa model, Shepherd Strategies has released a must-read white paper:
“The Medispa Revolution: Innovation, Accessibility, and Excellence in Aesthetic Medicine – Defending Patient Choice Against Regulatory Overreach”
This white paper lays out:
Prepared by a woman-owned government consulting and advocacy firm with deep experience in the aesthetic medicine space, it’s a smart, balanced, and passionate defense of innovation and patient choice.
Whether you’re a medispa owner, a provider, a patient who loves your local medispa, or simply someone who believes in accessible healthcare and small business success, this issue affects you.
Overregulation threatens to consolidate the industry into the hands of large corporate players, reducing options and raising prices for everyday Americans seeking confidence-boosting, wellness-focused care.
Shepherd Strategies is standing with the industry, offering strategic advocacy, policy shaping, compliance support, and public affairs expertise to protect this vital sector.
Don’t let alarmist narratives win. Arm yourself with the facts.
Download the white paper today. The future of aesthetic medicine should be defined by innovation, accessibility, and excellence—not bureaucratic overreach.
Let’s defend patient choice together.
© 2026 Shepherd Strategies LLC.
All Rights Reserved.
